Decreased expression of TFF2 and gastric carcinogenesis

Molecular and Cellular Toxicology

Volumn 6, Issue 3, 2010, Pages 261-269

  Jung, Kwang Hwa ^a   Kim, Pum Joon ^a   Kim, Jeong Kyu ^a   Noh, Ji Heon ^a   Bae, Hyun Jin ^a   Eun, Jung Woo ^a   Xie, Hong Jian ^a   Shan, Jin Mei ^b   Ping, Win Yin ^b   Park, Won Sang ^a   Lee, Jung Young ^a   Nam, Suk Woo ^a  

^a The Catholic University of Korea   (South Korea)

^b JILIN UNIVERSITY   (China)

Author keywords

Cell growth; Gastric cancer; Invasion; Motility; TFF2 expression

Indexed keywords

EID: 79951900491     PISSN: 1738642X     EISSN: 20928467     Source Type: Journal    
DOI: 10.1007/s13273-010-0036-z     Document Type: Article

References (42)

1. Bulitta, C. J. et al. Autoinduction of the trefoil factor 2 (TFF2) promoter requires an upstream cis-acting element. Biochem Biophys Res Commun 293:366-374 (2002). (Pubitemid 34694216)
2. Matsumoto, Y. et al. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med 13:470-476 (2007). (Pubitemid 46559833)
3. Maeda, K. et al. Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma. Cancer 86:566-571 (1999). (Pubitemid 29379401)
4. Alison, M. R. et al. Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach. J Pathol 175:405-414 (1995).
5. Taupin, D. & Podolsky, D. K. Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol 4:721-732 (2003). (Pubitemid 37082187)
6. Thim, L. Trefoil peptides: from structure to function. Cell Mol Life Sci 53:888-903 (1997). (Pubitemid 28021502)
7. Poulsom, R. Trefoil peptides. Baillieres Clin Gastroenterol 10:113-134 (1996). (Pubitemid 26125750)
8. Rio, M. C. et al. Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science 241:705-708 (1988).
9. Tomasetto, C. et al. hSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma. EMBO J 9:407-414 (1990).
10. Suemori, S., Lynch-Devaney, K. & Podolsky, D. K. Identification and characterization of rat intestinal trefoil factor: tissue-and cell-specific member of the trefoil protein family. Proc Natl Acad Sci USA 88:11017-11021 (1991). (Pubitemid 21915970)
11. Chadwick, M. P., Westley, B. R. & May, F. E. Homodimerization and hetero-oligomerization of the singledomain trefoil protein pNR-2/pS2 through cysteine 58. Biochem J 327 (Pt 1): 117):117-123 (1997). (Pubitemid 27455468)
12. Kinoshita, K., Taupin, D. R., Itoh, H. & Podolsky, D. K. Distinct pathways of cell migration and antiapoptotic response to epithelial injury: structure-function analysis of human intestinal trefoil factor. Mol Cell Biol 20:4680-4690 (2000). (Pubitemid 30396115)
13. Marchbank, T. et al. Dimerization of human pS2 (TFF1) plays a key role in its protective/healing effects. J Pathol 185:153-158 (1998). (Pubitemid 28270927)
14. Otto, W. R. et al. Effects of pancreatic spasmolytic Polypeptide (PSP) on epithelial cell function. Eur J Biochem 235:64-72 (1996). (Pubitemid 26048622)
15. Hanby, A. M. et al. Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology 105:1110-1116 (1993). (Pubitemid 23281500)
16. Podolsky, D. K. et al. Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem 268:6694-702 (1993). (Pubitemid 23099375)
17. Oertel, M. et al. Trefoil factor family-peptides promote migration of human bronchial epithelial cells: synergistic effect with epidermal growth factor. Am J Respir Cell Mol Biol 25:418-424 (2001). (Pubitemid 33037673)
18. Playford, R. J. et al. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 108:108-116 (1995).
19. Bossenmeyer-Pourie, C. et al. The trefoil factor 1 participates in gastrointestinal cell differentiation by delaying G1-S phase transition and reducing apoptosis. J Cell Biol 157:761-770 (2002). (Pubitemid 34847814)
20. Calnan, D. P. et al. The trefoil peptide TFF1 inhibits the growth of the human gastric adenocarcinoma cell line AGS. J Pathol 188:312-317 (1999). (Pubitemid 29317776)
21. Marchbank, T. et al. Effect of ectopic expression of rat trefoil factor family 3 (intestinal trefoil factor) in the jejunum of transgenic mice. J Biol Chem 276:24088-24096 (2001).
22. Taupin, D. R., Kinoshita, K. & Podolsky, D. K. Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. Proc Natl Acad Sci USA 97:799-804 (2000). (Pubitemid 30070390)
23. Lefebvre, O. et al. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 274:259-262 (1996). (Pubitemid 26353205)
24. Tebbutt, N. C. et al. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat Med 8:1089-1097 (2002). (Pubitemid 35175963)
25. Hippo, Y. et al. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 61:889-895 (2001). (Pubitemid 32174397)
26. Missiaglia, E. et al. Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis. Int J Cancer 112:100-112 (2004). (Pubitemid 39249497)
27. Cook, G. A., Familari, M., Thim, L. & Giraud, A. S. The trefoil peptides TFF2 and TFF3 are expressed in rat lymphoid tissues and participate in the immune response. FEBS Lett 456:155-159 (1999). (Pubitemid 29339060)
28. Farrell, J. J. et al. TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury. J Clin Invest 109:193-204 (2002). (Pubitemid 34083739)
29. Houghton, J. et al. Gastric cancer originating from bone marrow-derived cells. Science 306:1568-1571 (2004). (Pubitemid 39564955)
30. Dhar, D. K. et al. Expression of cytoplasmic TFF2 is a marker of tumor metastasis and negative prognostic factor in gastric cancer. Lab Invest 83:1343-1352 (2003). (Pubitemid 37140319)
31. Emami, S. et al. Trefoil factor family (TFF) peptides and cancer progression. Peptides 25:885-898 (2004). (Pubitemid 38721356)
32. Shi, S. Q., Cai, J. T. & Yang, J. M. Expression of trefoil factors 1 and 2 in precancerous condition and gastric cancer. World J Gastroenterol 12:3119-3122 (2006).
33. Chi, A. L., Lim, S. & Wang, T. C. Characterization of a CCAAT-enhancer element of trefoil factor family 2 (TFF2) promoter in MCF-7 cells. Peptides 25:839-847 (2004). (Pubitemid 38721351)
34. Vestergaard, E. M. et al. Immunoassays of human trefoil factors 1 and 2: measured on serum from patients with inflammatory bowel disease. Scand J Clin Lab Invest 64:146-156 (2004). (Pubitemid 38491386)
35. Dubeykovskaya, Z., Dubeykovskiy, A., Solal-Cohen, J. & Wang, T. C. Secreted trefoil factor 2 activates the CXCR4 receptor in epithelial and lymphocytic cancer cell lines. J Biol Chem 284:3650-3662 (2009).
36. Hoosein, N. M., Thim, L., Jorgensen, K. H. & Brattain, M. G. Growth stimulatory effect of pancreatic spasmolytic polypeptide on cultured colon and breast tumor cells. FEBS Lett 247:303-306 (1989). (Pubitemid 19129268)
37. Siu, L. S. et al. TFF2 (trefoil family factor2) inhibits apoptosis in breast and colorectal cancer cell lines. Peptides 25:855-863 (2004).
38. Otto, W. R. & Patel, K. Trefoil factor family (TFF) - domain peptides in the mouse: embryonic gastrointestinal expression and wounding response. Anat Embryol (Berl) 199:499-508 (1999). (Pubitemid 29204423)
39. Lalani, E. N. et al. Trefoil factor-2, human spasmolytic polypeptide, promotes branching morphogenesis in MCF-7 cells. Lab Invest 79:537-546 (1999). (Pubitemid 29228212)
40. Kononen, J. et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844-847 (1998). (Pubitemid 28331029)
41. Nam, S. W. et al. A sensitive screening assay for secreted motility-stimulating factors. Cell Motil Cytoskeleton 46:279-842 (2000).
42. Song, J. et al. Autotaxin (lysoPLD/NPP2) protects fibroblasts from apoptosis through its enzymatic product, lysophosphatidic acid, utilizing albumin-bound substrate. Biochem Biophys Res Commun 337:967-975 (2005). (Pubitemid 41447007)